These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 887229)

  • 41. [Prevention of cysteine calculosis by the continuous administration of alpha-mercaptopropionylglycine].
    Berio A
    Minerva Pediatr; 1983 Dec; 35(23-24):1197-1206. PubMed ID: 6425620
    [No Abstract]   [Full Text] [Related]  

  • 42. [Sulfhydryl-based treatment of rheumatoid arthritis (penicillamine, pyrithioxin, thiopronine)].
    Camus JP; Prier A; Cassou B; Bergevin H
    Rev Prat; 1980 Apr; 30(23):1517-8, 1521-3. PubMed ID: 7384712
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of gamma irradiation and radioprotector MPG on liver glycogen in mice.
    Khan AS; Bhartiya HC; Bhartiya KM
    Radiobiol Radiother (Berl); 1986; 27(4):473-7. PubMed ID: 3775007
    [No Abstract]   [Full Text] [Related]  

  • 44. 2-mercaptopropionylglycine in the treatment of the hyperviscosity syndrome.
    Triolo L; Magris D; Mian G
    Haematologica; 1980 Feb; 65(1):135. PubMed ID: 6768650
    [No Abstract]   [Full Text] [Related]  

  • 45. Influence of 2-mercaptopropionylglycine (MPG) on radiation-induced changes in the acid phosphatase activity of mouse intestine and its role in tissue protection.
    Mathur VB; Uma Devi P; Bisht KS
    Radiobiol Radiother (Berl); 1986; 27(4):479-84. PubMed ID: 3775008
    [No Abstract]   [Full Text] [Related]  

  • 46. Corticosteroid-induced changes in urea metabolism in patients with hepatocellular disease.
    Jones EA; Cain GD; Dickinson G
    Gastroenterology; 1972 Apr; 62(4):612-7. PubMed ID: 5020873
    [No Abstract]   [Full Text] [Related]  

  • 47. Chemical protection of mice against radiation induced sickness and mortality by 2-mercaptopropionylglycine.
    Kumar A; Uma Devi P
    Radiobiol Radiother (Berl); 1983; 24(2):231-4. PubMed ID: 6867303
    [No Abstract]   [Full Text] [Related]  

  • 48. [Tiopronine and rheumatoid polyarthritis].
    Amor B; Mery C; de Gery A; Zizi M
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):39-43. PubMed ID: 3704511
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Normotest in acute hepatitis and chronic liver disease.
    Ockerman PA; Braconier JH; Eriksson O
    Scand J Gastroenterol Suppl; 1973; 19():83-91. PubMed ID: 4515643
    [No Abstract]   [Full Text] [Related]  

  • 50. [Therapeutic effect of a preparation of total liver extract, cyanocobalamin and amino acids of the Krebs cycle, in acute and chronic liver diseases].
    Pignattari S; Sarti F; Toscano S; Dal Monte PR
    Minerva Med; 1972 Jul; 63(53):2861-72. PubMed ID: 5049878
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinico-epidemiological aspects of viral hepatitis in Canavese].
    Spaziante G; Spaziante B
    Riv Ital Ig; 1970; 29(1):49-78. PubMed ID: 5486912
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effect of 2 mercaptopropionylglycine on the cytotoxic activity of lymphocytes from patients with chronic active hepatitis against rabbit hepatocytes isolated and cultured in vitro].
    Mazzetti M; Guizzardi G; Meliconi R; Baraldini M; Stancari MV; Mazzoli M; Stefanini GF
    Boll Soc Ital Biol Sper; 1981 Jul; 57(14):1477-83. PubMed ID: 7295410
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical efficacy and adverse effects of tiopronin in rheumatoid arthritis. Report of a follow-up in 50 patients.
    Ambanelli U; Manganelli P; Ferraccioli GF
    Z Rheumatol; 1982; 41(5):235-9. PubMed ID: 7158085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical evaluation of plasmapheresis for hepatic disorders.
    Hida M; Watanabe J; Tanaka K; Kitamura M; Iida T; Hiraga S; Satoh T; Tanaka S; Kawamura Y; Tanaka M
    Tokai J Exp Clin Med; 1992 Dec; 17(5-6):223-7. PubMed ID: 1343429
    [No Abstract]   [Full Text] [Related]  

  • 55. Studies on radioprotectors in mammals and their possible use in radiotherapy--a summary.
    Kumar S
    Radiobiol Radiother (Berl); 1985; 26(3):359-65. PubMed ID: 2997830
    [No Abstract]   [Full Text] [Related]  

  • 56. [Anabolic steroids in the treatment of liver diseases].
    Mossor-Ostrowska J
    Pol Tyg Lek; 1971 Aug; 26(32):1248-51. PubMed ID: 4942579
    [No Abstract]   [Full Text] [Related]  

  • 57. Radioresponse of peripheral blood and its modification by MPG (2-mercaptopropionylglycine) in mice III leucocyte.
    Kumar S; Uma Devi P
    Radiobiol Radiother (Berl); 1983; 24(1):31-4. PubMed ID: 6856796
    [No Abstract]   [Full Text] [Related]  

  • 58. [Coagulation studies in liver diseases of children].
    Tschäppeler H; Gugler E
    Z Kinderheilkd; 1968; 103(4):349-64. PubMed ID: 5688626
    [No Abstract]   [Full Text] [Related]  

  • 59. [The behavior of radioactive colloidal gold clearance in hepatic cirrhosis treated with alpha-mercaptopropionyl-glycine].
    Bertoli L; Banfi F; Conti F
    Minerva Med; 1974 Feb; 65(15):830-3. PubMed ID: 4596803
    [No Abstract]   [Full Text] [Related]  

  • 60. Congenital hepatic fibrosis and nephronophthisis. A family study.
    Boichis H; Passwell J; David R; Miller H
    Q J Med; 1973 Jan; 42(165):221-33. PubMed ID: 4688793
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.